MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000553069

Медицинская библиотека · Oncology research and treatment · 2026

Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period.

Chakupurakal Geothy, Verpoort Karl, Kaiser Florian, Mohm Johannes, Feiten Stefan

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Immune thrombocytopenia (ITP) is an autoimmune disorder mostly treated in the outpatient setting. This study was conducted to analyze the real-world outcomes of outpatient care for ITP patients receiving treatment.

METHODS

Data from patients who had a diagnosis of primary ITP and on or requiring treatment between January, 2020 and December, 2021 in the routine outpatient practice were retrospectively analyzed.

RESULTS

Of 91 patients identified, at initial diagnosis, the mean age was 55 (range: 11-90). Eighty-one patients (89%) had a chronic ITP. The mean platelet count at the time of diagnosis was 26 g/L (range: 1-89 g/L). The primary indication for treatment was thrombocytopenia (n = 80, 88%); mean: 26.2 × 109/L (range: 1-89 × 109/L). The first-line treatment was mainly corticosteroids (56%, n = 51). The mean number of therapies and therapy lines was 3.45 (median: 2, range: 1-15) and 2.88 (median: 2, range: 1-10) respectively. Across all therapy lines, 82% of patients (n = 75) had corticosteroids, 77% (n = 70) thrombopoietin receptor agonists, 48% (n = 44) IVIG, 12% (n = 11) rituximab, 5% (n = 5) fostamatinib, and 6% (n = 7) splenectomy. A total of 314 therapies were administered during the study duration and patients achieved CR, R, and NR in 39% (123/314), 18% (56/314), and 43% (135/314), respectively. No grade III bleeding was documented during treatment.

CONCLUSION

We conclude that ITP can be safely managed in the outpatient setting despite the challenges involved in the care of this patient cohort. Close cooperation with regional hospitals allows inpatient care when necessary.

Для цитирования: Chakupurakal Geothy, Verpoort Karl, Kaiser Florian, Mohm Johannes, Feiten Stefan. Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period.. Oncology research and treatment. 2026. DOI: 10.1159/000553069.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.